Rhinovirus Associated Illness clinical trials

Explore recruiting rhinovirus associated illness clinical trials.

Also recruiting in Europe

Rhinovirus Associated Illness trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled Phase 2 study using the rhinovirus challenge model to investigate the efficacy and safety of 2-Deoxy-D-glucose as pre-exposure prophylaxis.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Rhinovirus Associated Illness trials by city

Rhinovirus Associated Illness in Toronto Rhinovirus Associated Illness in Vancouver Rhinovirus Associated Illness in Montreal Rhinovirus Associated Illness in Calgary Rhinovirus Associated Illness in Edmonton Rhinovirus Associated Illness in Ottawa Rhinovirus Associated Illness in Winnipeg Rhinovirus Associated Illness in Quebec City Rhinovirus Associated Illness in Hamilton Rhinovirus Associated Illness in Kitchener Rhinovirus Associated Illness in London Rhinovirus Associated Illness in Halifax Rhinovirus Associated Illness in New York Rhinovirus Associated Illness in Los Angeles Rhinovirus Associated Illness in Chicago Rhinovirus Associated Illness in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease